HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioGaia's New Boss Sets Out Growth Plans

Executive Summary

Former GSK Consumer Healthcare exec Theresa Agnew sees good opportunities for growth as Swedish probiotics player BioGaia, where she has served as CEO since the end of last year. 

You may also be interested in...

Strong Probiotics Demand in Americas Drives Up BioGaia's Q2 Sales

Higher sales of probiotics in the Americas and APAC helps offset a drop in turnover in EMEA for Sweden-based BioGaia in Q2.

People On The Move: Appointments At BioGaia, Futura, Unilever

A round-up of recent appointments in Europe's health and wellness markets: Swedish probiotics player BioGaia has named its next CEO, while Futura and Unilever have new chairmen.

Bayer Consumer Health Names New President In Surprise Move

Heiko Schipper is departing for Unilever with Bayer Consumer Health promoting Julio Triana to take over just days before a capital markets day which will set the future direction of the business.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts